Press coverage about AMERISAFE (NASDAQ:AMSF) has trended somewhat positive recently, Accern Sentiment Analysis reports. The research firm ranks the sentiment of news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. AMERISAFE earned a news sentiment score of 0.09 on Accern’s scale. Accern also assigned news headlines about the insurance provider an impact score of 46.9490547552232 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next few days.
These are some of the media stories that may have impacted Accern’s scoring:
- $92.63 Million in Sales Expected for AMERISAFE, Inc. (AMSF) This Quarter (americanbankingnews.com)
- AMERISAFE, Inc. (AMSF) Receives Consensus Rating of “Buy” from Analysts (americanbankingnews.com)
- Why the Earnings Streak Will Continue for Amerisafe (AMSF) (finance.yahoo.com)
- Is Amerisafe (AMSF) a Great Stock for Value Investors? (finance.yahoo.com)
- FY2018 Earnings Forecast for AMERISAFE, Inc. Issued By Boenning Scattergood (AMSF) (americanbankingnews.com)
Several equities analysts have weighed in on the company. B. Riley restated a “buy” rating on shares of AMERISAFE in a report on Monday, November 6th. SunTrust Banks restated a “buy” rating and issued a $69.00 price objective on shares of AMERISAFE in a research report on Friday, October 27th. Boenning Scattergood reiterated a “hold” rating on shares of AMERISAFE in a research report on Thursday, October 26th. FBR & Co reiterated a “buy” rating on shares of AMERISAFE in a research report on Wednesday, October 25th. Finally, Zacks Investment Research cut shares of AMERISAFE from a “buy” rating to a “hold” rating in a research report on Friday, September 15th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. AMERISAFE has a consensus rating of “Buy” and an average target price of $66.00.
AMERISAFE (NASDAQ:AMSF) last issued its quarterly earnings results on Wednesday, October 25th. The insurance provider reported $0.87 EPS for the quarter, topping analysts’ consensus estimates of $0.79 by $0.08. AMERISAFE had a net margin of 17.07% and a return on equity of 13.92%. The company had revenue of $92.90 million for the quarter, compared to analyst estimates of $92.04 million. During the same quarter in the previous year, the business earned $0.93 earnings per share. AMERISAFE’s revenue was down 5.4% compared to the same quarter last year. equities research analysts forecast that AMERISAFE will post 3.22 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Thursday, December 28th. Shareholders of record on Thursday, December 14th were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 1.30%. The ex-dividend date was Wednesday, December 13th. AMERISAFE’s dividend payout ratio (DPR) is currently 23.81%.
In other AMERISAFE news, CEO G. Janelle Frost sold 1,728 shares of AMERISAFE stock in a transaction on Tuesday, November 7th. The shares were sold at an average price of $66.74, for a total value of $115,326.72. Following the completion of the sale, the chief executive officer now directly owns 54,322 shares of the company’s stock, valued at $3,625,450.28. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Insiders own 2.20% of the company’s stock.
AMERISAFE Company Profile
Amerisafe, Inc is an insurance holding company. The Company is engaged in providing workers’ compensation insurance focused on small to mid-sized employers engaged in hazardous industries, principally construction, trucking, logging and lumber, manufacturing, and agriculture. It is engaged in underwriting the workers’ compensation exposures inherent in these industries.
Receive News & Ratings for AMERISAFE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AMERISAFE and related companies with MarketBeat.com's FREE daily email newsletter.